Intercept Pharma’s obeticholic acid (OCA) – trying to become the first FDA-approved therapy for non ... closing down nearly 14%. The US regulator is scheduled to make a decision on the ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat movement-related symptoms of Parkinson's disease, the drugmaker said on Tuesday.

Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...

“Today’s approval is an important public health milestone in acute pain management,” Jacqueline Corrigan-Curay, the acting director of the FDA's Center for Drug Evaluation and ...

NEW YORK -- More automotive and aerospace shipments to the U.S. are under scrutiny as officials step up efforts to block imports believed to have been made with Uyghur forced labor, data from the ...

(CNN) – The ... approved the first new type of pain medication in more than two decades, and it’s not an opioid. The drug is suzetrigine under the brand name Journavx. It is now FDA-approved ...

(Bloomberg) -- The US Securities and Exchange Commission on Thursday approved part of an application for a novel exchange-traded fund that would track the two largest cryptocurrencies. The Bitwise ...